Investing.com - Financial Markets Worldwide

Revvity stock price target lowered to $100 at Jefferies on China headwinds

Published 28/07/2025, 18:36
Revvity stock price target lowered to $100 at Jefferies on China headwinds
RVTY
0.38%

Investing.com - Jefferies lowered its price target on Revvity Inc (NYSE:RVTY) to $100.00 from $106.00 on Monday, while maintaining a Hold rating on the stock. According to InvestingPro data, the company currently trades at a P/E ratio of 39.45 and shows a perfect Piotroski Score of 9, indicating strong financial health.

The price target reduction follows Revvity’s guidance adjustment related to China’s drug-related group (DRG) policies, which Jefferies notes will impact the company’s financial outlook despite previous assurances about value-based procurement (VBP) concerns.

According to Jefferies, these China headwinds are expected to reduce Revvity’s organic revenue and earnings per share by approximately 1% each, raising questions about the sustainability of the company’s software business trends.

The research firm also expressed concerns about Revvity’s mid-term operating profit margin outlook, noting expectations that the company will enter 2026 with margins around 28%.

Jefferies questioned why Revvity’s cost-cutting measures have been unable to offset these headwinds in the current year, comparing the situation to competitor Danaher (NYSE:DHR)’s more effective cost management approach.

In other recent news, Revvity Inc. reported its second-quarter 2025 earnings, outperforming analyst expectations. The company posted an adjusted earnings per share (EPS) of $1.18, surpassing the forecasted $1.14. Additionally, Revvity’s revenue reached $720 million, exceeding the anticipated $710.39 million. These results highlight the company’s strong financial performance for the quarter. Despite the positive earnings and revenue results, the stock experienced a premarket decline. This development is part of recent updates concerning the company. Investors may find these financial results noteworthy as they reflect Revvity’s ability to exceed market expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.